Diabetes & Obesity

Losing Weight May Let You Cut Blood Pressure Meds

A study found that people with type 2 diabetes and high blood pressure who lost weight through a dietary program — about 25 pounds on average over 12 months — were able to cut back on their high blood pressure medications, yet their blood pressure stayed just as well controlled as before. In fact, their heart rate and certain measures of blood pressure fluctuation during the night also improved. This is early research and hasn't yet changed treatment guidelines.

Plant-based low-carb diets may help you lose 11-15 pounds

Researchers found that eating a low-carbohydrate diet built around plant foods — think vegetables, nuts, legumes, and whole grains, while cutting back heavily on bread, sugar, and starchy foods — helped people with obesity or related health conditions lose roughly 5 to 7 kilograms (about 11 to 15 pounds). The same approach also lowered harmful LDL cholesterol and improved blood sugar level (A1C), which measures how well the body has been managing blood sugar over the past few months. These results came from seven studies involving nearly 1,000 adults and lasted anywhere from about one month to one year.

Diabetes may not limit weight loss from GLP-1 drugs

Researchers found that people with type 2 diabetes tend to lose less weight on a diabetes medication like Ozempic or Victoza compared to people who have obesity but not diabetes — but when factors like age, body weight, and other health conditions were accounted for, type 2 diabetes itself may not be the direct reason for that difference. This suggests the gap in weight loss might be explained by other characteristics common in people with type 2 diabetes, such as high blood pressure or differences in starting body weight, rather than diabetes acting as a barrier on its own. This is early research and hasn't yet changed treatment guidelines.

Weight loss drugs may reduce how much you move

A press release highlights an interesting finding: people who started taking a diabetes medication like Ozempic or Wegovy for weight loss were also moving less — taking fewer daily steps and exercising less — even as they lost weight. This matters because these medications can reduce muscle along with fat, and being less active could make that muscle loss worse over time, which affects strength and overall health. This is early research and hasn't yet changed treatment guidelines.

New guidelines link heart, kidney, and diabetes risks

According to the American Heart Association, American College of Cardiology, American Diabetes Association, and American Society of Nephrology guidelines, people with type 2 diabetes often face overlapping risks involving the heart, kidneys, and metabolism — and these guidelines are designed to help doctors manage all of those risks together rather than treating each one separately. This matters because heart disease and kidney disease are closely connected to diabetes, meaning addressing them as a group can lead to better overall care. These guidelines are intended to give doctors — including heart specialists, diabetes specialists, kidney specialists, and primary care providers — a shared, up-to-date approach to protecting their patients' health.

Diabetes pills might offer Ozempic-like benefits

Researchers found that pill-form versions of a diabetes medication like Ozempic or Victoza — which were previously only available as injections — could open up new options for treating both type 2 diabetes and obesity, since weight loss is now seen as an important part of managing type 2 diabetes. This matters because a daily pill might be easier for some people to take than a weekly injection. This is early research and hasn't yet changed treatment guidelines.

New diabetes drug may beat Ozempic for weight loss

Researchers found that tirzepatide, a newer diabetes medication that works on two hormone pathways at once, did a better job of lowering blood sugar level (A1C) and helping people lose weight compared to semaglutide — a well-known diabetes medication like Ozempic or Victoza — in people with type 2 diabetes. The idea behind this research is that targeting more than one hormone signal in the body might work better than targeting just one, which could matter a lot for people trying to manage both their blood sugar and their weight. This is early research and hasn't yet changed treatment guidelines.

New pill might burn fat without Ozempic's side effects

A press release describes an experimental pill being developed for type 2 diabetes and obesity that works differently from a diabetes medication like Ozempic or Victoza — instead of reducing appetite, it targets the muscles to help the body burn fat and manage blood sugar control, while keeping muscle mass intact. Early results suggest it appears to be safe and well tolerated by patients. Because this is a press release about early-stage research and not yet a published study, it's worth watching but hasn't yet changed treatment guidelines.

Why Exercise Gets Harder on Weight Loss Drugs

A study explored how exercise fits into weight loss plans, especially for people taking a diabetes medication like Ozempic or Victoza, and found that getting patients to stick with regular exercise is a real challenge for doctors. Researchers looked at strategies that could help people stay consistent with physical activity, whether or not they're on these medications. This matters because exercise likely plays an important supporting role in weight management, and patients might want to ask their doctor what realistic, personalized movement goals could look like for them.

Moving more might boost health even without weight loss

A study found that regularly moving your body — through activities like walking, cycling, or other exercise done on a consistent basis — improves several health measures in people with overweight or obesity, including blood pressure, how well the body responds to insulin (which helps manage blood sugar), cholesterol levels, and heart and lung fitness. Importantly, researchers found these benefits happen regardless of whether a person loses weight. This means that getting active regularly can improve how the body works on the inside, even when the number on the scale doesn't change.

Exercise helps your health even without weight loss

Researchers found that adults with obesity who exercise regularly — meaning consistent physical activity as a habit, not just occasional movement — can improve their high blood pressure, cholesterol, and how well their body handles blood sugar, even if the number on the scale doesn't change. The benefits came from the activity itself, not from losing weight. This suggests that staying active has real health value for people with obesity beyond just burning calories.

Plant-based eating may cut heart disease risk

This research combined data from 23 studies and found that people with type 2 diabetes — and adults generally — who closely followed the Planetary Health Diet (an eating pattern built around vegetables, fruits, whole grains, legumes like beans and lentils, and nuts, with little red meat or processed food) had about 17–18% lower chances of death or serious heart problems like heart attacks or strokes. The benefit wasn't all-or-nothing: meaningful risk reductions appeared once people reached a moderate-to-high level of the diet, suggesting that gradually eating more plants and less processed meat — even starting with one meal today — may matter. The researchers note these studies show a strong link but can't yet prove the diet directly causes these better outcomes, so this is promising but not the final word.

Diabetes drugs may help ease anxiety

Researchers found that a diabetes medication like Ozempic or Victoza may do more than manage blood sugar — it might also help reduce anxiety. In animal studies, the medication consistently calmed anxiety-like behaviors, and in human studies, people taking it showed some signs of lower anxiety and reduced risk of suicidal thoughts, though the human results were mixed. This is early research and hasn't yet changed treatment guidelines.

New combo drug may boost weight loss better than Ozempic alone

Researchers found that combining two medications — cagrilintide and a diabetes medication like Ozempic or Victoza (semaglutide) — helped people with obesity lose significantly more weight than taking the diabetes medication alone, in a study involving people in Japan and Taiwan. Both medications were given as once-weekly injections over about 16 months, alongside lifestyle changes. This is early research and hasn't yet changed treatment guidelines.

Weight loss program may save money while reversing diabetes

A study found that a structured weight loss program helped some people with type 2 diabetes go into remission — meaning their blood sugar returned to a normal range without medication — and that this approach actually saved money over five years compared to standard care, largely because participants needed fewer hospital stays and less medication. Researchers found that the program cost about £1,691 per person but led to roughly £2,091 in healthcare savings per person, making it cost-effective over the long run. People with type 2 diabetes may want to ask their doctor whether a structured, low-calorie weight management program could be a suitable option for them.

Diabetes drugs may cause muscle loss alongside weight loss

A study found that when people with obesity lost weight using diabetes medications like Ozempic or Victoza (including newer versions that work two ways at once), roughly a quarter to a third of the weight they lost came from muscle rather than fat — a pattern that was similar to what happened with diet and exercise changes alone. The most encouraging finding was that adding resistance training (such as weightlifting or strength exercises) to a lifestyle program led to the least amount of muscle loss during weight loss, compared to any other approach studied. For someone with obesity, this matters because keeping muscle while losing weight helps maintain strength and long-term health. This is early research and hasn't yet changed treatment guidelines.

New drug may beat Ozempic for weight loss

Researchers found that among several diabetes medications like Ozempic or Victoza used for weight loss, tirzepatide (sold as Mounjaro or Zepbound) stood out as the most effective at helping people with obesity lose a meaningful amount of weight — whether or not they also had Type 2 diabetes — with people being up to 14 times more likely to lose 10% or more of their body weight compared to those taking a placebo (a dummy treatment with no active medicine). This matters because losing even 5–10% of body weight can significantly improve health outcomes for people living with obesity, and this large review pooled results from 127 studies and nearly 59,000 participants, giving it more weight than a single study alone. This is early research and hasn't yet changed treatment guidelines.

Diabetes drugs may be safe with stomach issues

According to Italian Society of Gastroenterology (SIGE) guidelines, a diabetes medication like Ozempic or Victoza can be safely used by people with type 2 diabetes or obesity who also have liver or digestive conditions, and there is no need to stop taking it before a routine stomach scope procedure. The guidelines also note that these medications do not appear to raise the risk of cancers in the stomach, colon, or pancreas, and may even lower the chances of a specific type of liver cancer. People taking this type of medication may experience mild, temporary digestive side effects — like nausea or stomach upset — and a higher chance of developing gallstones (hard deposits that form in the gallbladder), but serious digestive complications do not appear to be a concern.

Short, intense workouts may lower blood pressure best

A study found that for people with metabolic syndrome — a cluster of conditions including high blood pressure, excess belly fat, and blood sugar problems — high-intensity interval training (short bursts of hard effort followed by rest) was the most effective type of exercise for lowering blood pressure, outperforming steady aerobic exercise, strength training, and mind-body practices like yoga or tai chi. The benefits were especially noticeable in people who already had high blood pressure and in those who kept up their exercise program for 16 weeks or longer. This is early research and hasn't yet changed treatment guidelines.

Diabetes drugs may ease sleep apnea breathing problems

Researchers found that people with moderate-to-severe sleep apnea tend to have lower levels of a natural gut hormone (called GLP-1) that helps regulate blood sugar, and that taking a diabetes medication like Ozempic or Victoza may help reduce the number of breathing interruptions during sleep, improve blood sugar control, and lower body weight in people who have sleep apnea alongside obesity or diabetes. This could matter because it suggests there may be a biological link between sleep apnea and blood sugar regulation that doctors might one day be able to target with existing medications. This is early research and hasn't yet changed treatment guidelines.

Low-carb and low-fat diets may fight inflammation equally

Researchers found that eating a low-carbohydrate diet (where roughly 1 in 4 calories comes from carbs, like bread, pasta, and sugar) and eating a low-fat diet (where about 1 in 4 calories comes from fat) produced nearly identical results when it came to reducing inflammation in people with obesity — inflammation being the body's low-level, ongoing stress response that can quietly raise the risk of disease. The study looked at 25 separate studies involving over 2,000 adults, following them for an average of about six months. In short, neither eating style had a clear edge over the other for calming inflammation markers in the body.

New dual-action diabetes drug may help you lose more weight

Researchers found that tirzepatide (brand name Mounjaro), a diabetes medication like Ozempic or Victoza but with a dual-action formula, helped people with type 2 diabetes and obesity lose significantly more weight and improve their blood sugar level (A1C) compared to insulin and similar medications. The study, which looked at 13 separate trials involving over 14,000 people, also found that tirzepatide caused fewer serious side effects and less dangerously low blood sugar than insulin, though it did cause more stomach-related issues like nausea. This is a new research finding — not a guideline — suggesting tirzepatide may be a strong option in this treatment space, though people with these conditions should talk with their doctor about what's right for them.

Virtual weight loss program + glucose monitor may help control blood sugar

A study found that people with type 2 diabetes who took part in an online weight management program combined with a continuous glucose monitor — a small wearable device that tracks blood sugar throughout the day — had better blood sugar level (A1C) and greater weight loss after six months compared to people who only met with a dietitian and received educational materials. Participants in the program also reported feeling less stressed about managing their diabetes and more satisfied with their care. This is early research and hasn't yet changed treatment guidelines.

Distracted eating may lead to eating more

Researchers found that eating while watching TV or doing something passive — like listening to a podcast — led people to eat noticeably more food compared to eating without any distraction. However, when the distraction involved physical activity, that effect wasn't seen. For people managing obesity, this matters because small, repeated increases in how much is eaten during passive screen time could add up over time. This is early research and hasn't yet changed treatment guidelines.

Your diet may affect how your liver handles blood sugar

Researchers found that people who ate more red meat, processed meat, and cream — while eating less fruit, vegetables, and tea — were more likely to have problems with how their liver processed insulin, a hormone that helps control blood sugar. This "insulin resistance" in the liver makes it harder for the body to keep blood sugar levels steady, which is a key concern for people with type 2 diabetes. This is early research and hasn't yet changed treatment guidelines.

Weight-loss drugs may cut heart attack risk

A large international review found that a diabetes medication like Ozempic — also used for weight loss — significantly lowers the chances of serious heart problems like heart attacks or strokes, heart failure, and early death in people with type 2 diabetes. Researchers believe these medications could play a major role in protecting heart health, beyond just managing weight and blood sugar. This appears to be an emerging finding about a broader benefit of medications that were already in use.

Diabetes pill may help weight loss and blood sugar

Researchers found that oral semaglutide — a diabetes and weight-loss medication known by the brand name Rybelsus (the pill form of the same drug in Ozempic) — helped people with overweight or obesity lose weight and improve their blood sugar level (A1C) compared to a placebo, or sugar pill. The analysis pulled together results from 13 studies involving more than 26,000 people, making it a fairly large look at the evidence. This appears to be a new finding adding to what we know about how the pill form of this medication may help with weight and heart-health-related factors beyond just blood sugar control.

Modified Mediterranean diet may cut diabetes risk by 31%

A press release describes findings suggesting that people who followed a calorie-reduced Mediterranean diet — meaning they ate less overall while still focusing on vegetables, fruits, whole grains, and healthy fats — and combined it with regular physical activity and personal coaching were 31% less likely to develop type 2 diabetes over six years compared to those who followed a standard Mediterranean diet alone. They also lost more weight and reduced the size of their waistline, which matters because excess belly fat is closely linked to blood sugar problems. This approach involved ongoing support through coaching, not just a diet pamphlet, suggesting the guidance and accountability played a meaningful role.

Plant-Based Diet May Help Your Heart Health

A study found that eating more plant-based foods — like vegetables, beans, nuts, and whole grains — while cutting back on red meat and processed meat may help improve heart health in people with type 2 diabetes. Researchers found this shift in eating habits was linked to a lower chance of serious heart problems like heart attacks or strokes. The findings suggest that what people put on their plate regularly can make a meaningful difference for their heart over time.

30 Minutes of Exercise Weekly May Transform Your Health